Will leverage PolyPeptide’s peptide manufacturing and development services and Lifecore’s formulation, fill/finish, and packaging services.

Lifecore Biomedical, Inc., a an integrated CDMO, and PolyPeptide Laboratories, Inc ., a global peptide contract development and manufacturer, entered a collaboration agreement aimed at providing an ...

Biomedical and PolyPeptide Laboratories announced the signing of a collaboration agreement aimed at providing an integrated, ...

Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization ...

Suzhou Spring-Sea Bio-Pharmaceuticals Co. Ltd. has described polypeptides acting as glucagon-like peptide 1 receptor (GLP-1R), glucagon receptor (GCGR) and gastric inhibitory polypeptide receptor ...

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

DOUGLAS, ISLE OF MAN, GB / / October 21, 2025 / Agronomics (LSE:ANIC), the leading listed company in the field of clean food, is pleased to announce that ...

"The beauty and longevity revolution demands both breakthrough science and the infrastructure to deliver it," according to ...

The newer generation of glucose-lowering agents, such as GLP-1 receptor agonists, enable many patients to reach glycaemic treatment goals, with cardiovascular risk reduction, and the additional ...

Prominent players in the market include Bachem AG, PolyPeptide Group, CPC Scientific Inc., Lonza Group Ltd., CordenPharma ...